Innate defence against tumor cells: The killer cell IKDC;Une défense naturelle contre les cellules tumorales? Oui, la cellule tueuse IKDC

Bulletin du Cancer

Volumn 93, Issue 5, 2006, Pages 449-451

  Chaput, Nathalie ^a   Taieb, Julien ^a   Zitvogel, Laurence ^a  

^a INSERM   (France)

Author keywords

Dendritic cell; IFN producing killer dendritic cell

Indexed keywords

GAMMA INTERFERON; IMATINIB; INTERLEUKIN 2; PERFORIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ANTINEOPLASTIC AGENT; INTERFERON; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; CELL ACTIVITY; CELL PROLIFERATION; DEFENSE MECHANISM; DENDRITIC CELL; DRUG ACTIVITY; INNATE IMMUNITY; INTERFERON PRODUCING KILLER DENDRITIC CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; REVIEW; TUMOR CELL; TUMOR CELL DESTRUCTION; TUMOR LOCALIZATION; ADOPTIVE TRANSFER; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL MOTION; CELLULAR IMMUNITY; COLON TUMOR; CYTOLOGY; EXPERIMENTAL MELANOMA; IMMUNOLOGY; IMMUNOSURVEILLANCE; METHODOLOGY; PHENOTYPE;

ADOPTIVE TRANSFER; ANIMALS; ANTINEOPLASTIC AGENTS; CELL MOVEMENT; COLONIC NEOPLASMS; DENDRITIC CELLS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; IMMUNOLOGIC SURVEILLANCE; INTERFERONS; INTERLEUKIN-2; KILLER CELLS, NATURAL; MELANOMA, EXPERIMENTAL; MICE; PHENOTYPE; PIPERAZINES; PYRIMIDINES;

EID: 33745305978     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, Van Pel A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 1994; 12: 337-65.
2. Banchereau J, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
3. Rosenberg SA. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol Today 1997; 18: 175-82.
4. Shankaran V, et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001; 410: 1107-11.
5. Boon T, van Baren N. Immunosurveillance against cancer and immunotherapy-synergy or antagonism? N Engl J Med 2003; 348: 252-4.
6. NK cell-based immunotherapy: new prospects and involvement of dendritic cells. Bull Cancer 2003: 90699-705.
7. Taieb J, et al. A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med 2006: 12214-9; (Epub 2006 Jan 29).
8. Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature 2001; 411: 380-4.
9. Chan CW, et al. IFN producing killer DC provide a link between innate and adaptive immunity. Nat Med 2006; 12: 207-13.